Short answer
Neurogene Inc. (NGNE) filed an 8-K current report with the SEC on August 11, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Exhibits 99.1 and 99.2 furnished under Item 2.02, likely containing the earnings disclosure.
Neurogene Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Exhibits 99.1 and 99.2 furnished under Item 2.02, likely containing the earnings disclosure
- Materials not deemed filed under Exchange Act Section 18, limiting liability exposure
- Exhibits excluded from incorporation by reference unless expressly cited in another filing
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Neurogene Inc. 8-K filings
Get the next NGNE 8-K as it lands
Follow NGNE for push alerts, or ask the research agent what this filing means.